Skip to main content
Partner NO

Norwegian Cancer Society

NCS
← Back to partners Visit organisation website

Programme phases

2

Funding participation

Joint calls funded by this organisation.

8
JTC 2024
2024
JTC 2023
2023
JTC 2022
2022
JTC 2021
2021
JTC 2016
2016
JTC 2014
2014
JTC 2013
2013
JTC 2012
2012

Funded projects

Projects linked to this funding organisation.

12
FOCUS

Biomarkers related to folate-dependent one-carbon metabolism in CRC recurrence and survival

JTC 2013
View project
GENMEL

Identification of genetic markers involved in development of metastases and second cancers in melanoma

JTC 2013
View project
GLIOMA-PRD

Multiparameric Analysis of the Evolution and Progression of Low-Grade Glioma (LGG)

JTC 2016
View project
HetMet

Intratumour heterogeneity, clonal selection and metastatic propensity in breast cancer

JTC 2014
View project
ImmuMet

Invigorating immunity against brain metastases in lung and breast cancer patients

JTC 2021
View project
ITEM

Dissecting phenotypic heterogeneity of human melanoma: building a rationale for active immunotherapies overcoming immunologically-induced dedifferentiation.

JTC 2014
View project
MetBreCS

A randomized placebo controlled phase II study with Metformin in metabolic-unbalanced breast cancer survivors at higher risk for recurrence

JTC 2013
View project
NK-4-GBM

Metabolically optimised NK cell therapies for Glioblastoma

JTC 2022
View project
PERIMMUNE

INTRAPERITONEAL IMMUNE MODULATION FOR COLORECTAL PERITONEAL METASTASES

JTC 2021
View project
PROSCANEXO

Exploitation of extracellular vesicles for precision diagnostics of prostate cancer

JTC 2016
View project
SCRAtCH

Microbiota-based screening of anal cancer in HIV-infected individuals

JTC 2016
View project
TALETE

TArgeting acute myeloid Leukemia immunosuppressive microEnvironment by combined IDO1 inhibiTion and PD-1 blockadE

JTC 2021
View project